11 results ยท Page 1 of 1
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|
| Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection | Pre-Exposure Prophylaxis of HIV Infection | Active, not recruiting | Phase 3 | 2026-10-06 | | NCT04925752 |
|---|
| Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance | HIV-1-infection | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-01 | | NCT04150068 |
|---|
| Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen | HIV-1-infection | Active, not recruiting | Phase 2 / Phase 3 | 2026-08-10 | | NCT05502341 |
|---|
| HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study | HIV -1 Infection | Active, not recruiting | Phase 2 | 2026-08-06 | | NCT07215468 |
|---|
| Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy | HIV-1-infection | Active, not recruiting | Phase 3 | 2026-06-15 | | NCT06333808 |
|---|
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 | HIV-1-Infection | Active, not recruiting | Phase 3 | 2026-05-29 | | NCT06630299 |
|---|
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 | HIV-1-infection | Active, not recruiting | Phase 3 | 2026-04-30 | | NCT06630286 |
|---|
| A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection | HIV-1 Infection | Active, not recruiting | Phase 2 | 2026-04-27 | | NCT05729568 |
|---|
| Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed | HIV-1-Infection | Active, not recruiting | Phase 2 / Phase 3 | 2026-04-17 | | NCT06544733 |
|---|
| Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV | HIV-1 Infection | Active, not recruiting | Phase 2 | 2026-02-04 | | NCT05052996 |
|---|
| Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study | HIV-1-infection | Active, not recruiting | Phase 4 | 2025-08-03 | | NCT05220358 |
|---|